AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TRISTEL PLC

Report Publication Announcement Jul 19, 2017

7990_rns_2017-07-19_c0923e74-f156-4ea5-a4bf-8b9ebd1f1ef2.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4226L

Tristel PLC

19 July 2017

Tristel plc

("Tristel" or "the Company")

Trading update & Notice of results

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, provides a trading update for the year ended 30 June 2017 in conjunction with today's Shareholder Open Day at its headquarters in Snailwell, Cambridgeshire. 

For the year ended 30 June 2017 Tristel will record turnover in excess of £20 million (2016: £17.1 million) and pre-tax profit (before share-based payments) of at least £4 million (2016: £3.3 million). Both turnover and pre-tax profit are ahead of market expectations. In the second half, revenue from overseas markets contributed 50% of the Group total compared to 43% in the first half, and for the full year overseas revenue represented 47% of Group revenue - a record level. Tristel has continued to generate significant levels of cash and at 30 June 2017 cash balances were £5.1 million (30 June 2016: £5.7 million). The Company has no debt.

During the year ended 30 June 2017, the Company spent £0.95 million on the acquisition of its Australian distributor, distributed an aggregate £2.8 million in dividends including a special dividend announced in July last year, incurred costs of £0.5 million in association with its North American market entry - the fruits of which were announced earlier in the month with our first submission to the EPA. The Company also invested US$0.75 million in Mobile ODT, a business combining smartphone technology with hand-held medical devices for point-of-care diagnostics.

The Company will declare a final dividend for the year at the time of the preliminary results to be announced in October. The Board is currently considering its dividend policy and the ongoing cash requirements of the business as it continues its global expansion.

Shareholder Open Day

Tristel is today hosting an Open Day for Shareholders at the Company headquarters in Snailwell, Cambridgeshire. A presentation will be made during the Open Day; however, it will contain no new material information and will be available on the Company website: www.tristel.com/investor-centre

Notice of results

The Company expects to announce its preliminary results for the year ended 30 June 2017 on 19 October 2017. 

Francisco Soler, Chairman of Tristel plc, comments: "The Company enjoyed a very strong second half with overseas sales continuing to drive progress. The Australian acquisition that we announced at the Open Day event in July last year made a significant contribution to this growth and we consider it as having been a success. We are pleased that overseas sales in the year represented almost half of the total and we anticipate that our overseas operations will continue to expand."  

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014

For further information please contact:

Tristel plc Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Finance Director
Walbrook PR Ltd Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07854 391 303
finnCap Tel: 020 7220 0500
Geoff Nash/ Giles Rolls (Corporate Finance)
Alice Lane (Corporate Broking)

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTZVLFFDDFEBBE

Talk to a Data Expert

Have a question? We'll get back to you promptly.